Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Witt

Showing results (31-40 of 51) with videos related to

Pageof 6
Sort By:
Blood|April 1, 1995
Blood-derived autografts collected during granulocyte colony-stimulating factor-enhanced recovery are enriched with early Thy-1+ hematopoietic progenitor cellsR Haas, R Möhle, M Pförsich, et al.
Blood|May 1, 1995
Peripheral blood progenitor cell (PBPC) counts during steady-state hematopoiesis allow to estimate the yield of mobilized PBPC after filgrastim (R-metHuG-CSF)-supported cytotoxic chemotherapyS Fruehauf, R Haas, C Conradt, et al.
Journal of Hematotherapy|January 1, 1994
Characterization of peripheral blood progenitor cells mobilized by cytotoxic chemotherapy and recombinant human granulocyte colony-stimulating factorR Haas, R Möhle, S Murea, et al.
Seminars in Oncology|December 1, 1994
High-dose therapy and autografting with peripheral blood stem cells in malignant lymphoma: granulocyte-macrophage colony-stimulating factor for stem cell mobilizationR Haas, S Hohaus, H Goldschmidt, et al.
Metallomics : Integrated Biometal Science|April 25, 2017
Arsenolipids exert less toxicity in a human neuron astrocyte co-culture as compared to the respective monoculturesB Witt, J Bornhorst, H Mitze, et al.
Blood|June 15, 1994
Patient characteristics associated with successful mobilizing and autografting of peripheral blood progenitor cells in malignant lymphomaR Haas, R Möhle, S Frühauf, et al.
Blood|June 15, 1995
Sustained long-term hematopoiesis after myeloablative therapy with peripheral blood progenitor cell supportR Haas, B Witt, R Möhle, et al.
Family Medicine|April 12, 2023
More Than Half of Family Medicine Clerkships Do Not Address Systemic Racism: A CERA StudyKristina M Bridges, Kathryn Rampon, Natabhona Mabachi, et al.
Bone Marrow Transplantation|December 1, 1993
Autografting with peripheral blood stem cells mobilized by sequential interleukin-3/granulocyte-macrophage colony-stimulating factor following high-dose chemotherapy in non-Hodgkin's lymphomaR Haas, R Ehrhardt, B Witt, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|May 1, 1995
[Sequential high-dose therapy in patients with low-malignity non-Hodgkin's lymphoma]R Haas, M Moos, A Karcher, et al.
Pageof 6

Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
Blood|April 1, 1995
Blood-derived autografts collected during granulocyte colony-stimulating factor-enhanced recovery are enriched with early Thy-1+ hematopoietic progenitor cellsR Haas, R Möhle, M Pförsich, et al.
Blood|May 1, 1995
Peripheral blood progenitor cell (PBPC) counts during steady-state hematopoiesis allow to estimate the yield of mobilized PBPC after filgrastim (R-metHuG-CSF)-supported cytotoxic chemotherapyS Fruehauf, R Haas, C Conradt, et al.
Journal of Hematotherapy|January 1, 1994
Characterization of peripheral blood progenitor cells mobilized by cytotoxic chemotherapy and recombinant human granulocyte colony-stimulating factorR Haas, R Möhle, S Murea, et al.
Seminars in Oncology|December 1, 1994
High-dose therapy and autografting with peripheral blood stem cells in malignant lymphoma: granulocyte-macrophage colony-stimulating factor for stem cell mobilizationR Haas, S Hohaus, H Goldschmidt, et al.
Metallomics : Integrated Biometal Science|April 25, 2017
Arsenolipids exert less toxicity in a human neuron astrocyte co-culture as compared to the respective monoculturesB Witt, J Bornhorst, H Mitze, et al.
Blood|June 15, 1994
Patient characteristics associated with successful mobilizing and autografting of peripheral blood progenitor cells in malignant lymphomaR Haas, R Möhle, S Frühauf, et al.
Blood|June 15, 1995
Sustained long-term hematopoiesis after myeloablative therapy with peripheral blood progenitor cell supportR Haas, B Witt, R Möhle, et al.
Family Medicine|April 12, 2023
More Than Half of Family Medicine Clerkships Do Not Address Systemic Racism: A CERA StudyKristina M Bridges, Kathryn Rampon, Natabhona Mabachi, et al.
Bone Marrow Transplantation|December 1, 1993
Autografting with peripheral blood stem cells mobilized by sequential interleukin-3/granulocyte-macrophage colony-stimulating factor following high-dose chemotherapy in non-Hodgkin's lymphomaR Haas, R Ehrhardt, B Witt, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|May 1, 1995
[Sequential high-dose therapy in patients with low-malignity non-Hodgkin's lymphoma]R Haas, M Moos, A Karcher, et al.
Pageof 6